Opsens Reports Results of Shareholders Vote

QUEBEC CITY, Jan. 31, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX: OPS) (OTCQX: OPSSF) held its Shareholders' Annual Meeting ("the Meeting") on January 23, 2018. At the Meeting, all nominated directors were duly elected to Opsens' Board of Directors by a majority of votes cast by the shareholders present in person or by proxy as follows:

Shareholders present or represented by proxy at the meeting also voted by a proportion of 85.48% in favour of the appointment of Deloitte S.E.N.C.R.L./s.r.l, as independent auditors of Opsens for the ensuing year and authorizing the directors to determine their remuneration.

Please note that the voting results report is also available on SEDAR at www.sedar.com.

About Opsens Inc. ( www.opsens.com or www.opsensmedical.com )

Opsens focuses mainly on the measure of FFR in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

SOURCE OPSENS INC.

View original content: http://www.newswire.ca/en/releases/archive/January2018/31/c8674.html